Tuberculosis and HIV infection: the global setting

Paul Nunn1, Alasdair Reid, Kevin M De Cock

  • 1Stop TB Department, World Health Organization, Geneva, Switzerland. nunnp@who.int

Insights

Coordinating tuberculosis (TB) and human immunodeficiency virus (HIV) services is crucial but faces challenges. Strengthening global and national collaboration is essential for effective TB/HIV care and control.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Global Health Policy

Background:

  • Tuberculosis (TB) and human immunodeficiency virus (HIV) coinfection present significant challenges to disease control efforts.
  • The interplay between TB and HIV, termed the "cursed duet," complicates management and prevention strategies.
  • Current coordination between TB and HIV control programs is insufficient at both global and national levels.

Purpose of the Study:

  • To highlight the critical need for enhanced coordination in managing HIV-associated TB.
  • To advocate for the integration of TB control into global HIV policies and programs.
  • To identify barriers and propose strategies for effective implementation of TB/HIV care.

Main Methods:

  • Policy analysis of existing global TB/HIV coordination frameworks.
  • Review of implementation challenges, including technical difficulties and resource limitations.
  • Examination of the roles of global institutions, country-level decision-makers, and civil society.

Main Results:

  • Global policy for TB/HIV coordination exists, with community consensus, aiming for comprehensive care.
  • Implementation is hampered by practical technical hurdles and inadequate resources.
  • Effective coordination requires commitment from global HIV institutions, collaborative country-level action, and civil society engagement.

Conclusions:

  • Global institutions must integrate TB control into their HIV policies.
  • Country-level stakeholders must collaborate to expand integrated TB and HIV services.
  • Joint efforts by TB and HIV communities are vital to address shared health system weaknesses.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...